01 1SperaNexus Co., Ltd.
01 1Oxaprozin
01 1Japan
Registration Number : 217MF10040
Registrant's Address : 4-8-2 Nihonbashi Honcho, Chuo-ku, Tokyo
Initial Date of Registration : 2005-05-20
Latest Date of Registration : 2009-11-24
55
PharmaCompass offers a list of Oxaprozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxaprozin manufacturer or Oxaprozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxaprozin manufacturer or Oxaprozin supplier.
PharmaCompass also assists you with knowing the Oxaprozin API Price utilized in the formulation of products. Oxaprozin API Price is not always fixed or binding as the Oxaprozin Price is obtained through a variety of data sources. The Oxaprozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Walix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Walix, including repackagers and relabelers. The FDA regulates Walix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Walix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Walix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Walix supplier is an individual or a company that provides Walix active pharmaceutical ingredient (API) or Walix finished formulations upon request. The Walix suppliers may include Walix API manufacturers, exporters, distributors and traders.
click here to find a list of Walix suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Walix Drug Master File in Japan (Walix JDMF) empowers Walix API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Walix JDMF during the approval evaluation for pharmaceutical products. At the time of Walix JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Walix suppliers with JDMF on PharmaCompass.
